Albinism and its implications with vision

Insight - Journal of the American Society of Ophthalmic Registered Nurses

Volumn 34, Issue 2, 2009, Pages 13-16

  Kirkwood, Bradleyj ^a  

^a Eye Center   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN;

ARTICLE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HEALTH; HUMAN; METABOLISM; OCULAR ALBINISM; PATHOLOGY; PIGMENT EPITHELIUM; PREVALENCE; PROGNOSIS;

ALBINISM, OCULOCUTANEOUS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MELANINS; PIGMENT EPITHELIUM OF EYE; PREVALENCE; PROGNOSIS; WORLD HEALTH;

EID: 67650110037     PISSN: 1060135X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Traboulsi. EI. Green. WR. Chapter 38: An overview of albinism and its visual system manifestations. In: Tasman. W. Jaeger. EA. eds. Duane's Ophthalmology on CD-ROM 2006 Edition. Philadelphia: Lippincott. Williams and Wilkins; 2006.
2. Bashour. M. Hasanee. K. Ahmed. UK. Albinism. eMedicine from WebMD. Cited at: http://www.emedicine.com/oph/T0PICS315.HTM. Accessed on 31/08/2008.2007.
3. Garrod. AE. Inborn errors of metabolism. Lecture II. Lancet. 1908;2:73-79.
4. Gronskov. K. Ek. J. Brondum-Nielsen. K. Oculocutaneous albinism. Orphanet JRarc Dis. 2007:2:43.
5. Kincaid. MC. Yanoff. M. Fine. BS. Chapter 13: Retina. In: Tasman. W. Jaeger. EA. eds. Duane's Ophthalmology on CD-ROM 2006 Edition. Philadelphia: Lippincott. Williams and Wilkins; 2006.
6. Wildsoet. CF. Oswald. PJ. Clark. S. Albinism: Its implications for refractive development. Invest Ophthalmol Vis Sci. 2000;4l(l):l-7.
7. Kunal. R. Moumita. C. Mainak. S. Tyrosinase and ocular diseases: Some novel thoughts on the molecular basis of oculocutaneous albinism type 1. Progress in Retinal and Eye Research. 2007;26:323-358.
8. Centuri6n. SA. Schwartz. RA. Oculocutaneous albinism type 2. Acta DermatovenAPA. 2003;12:32-36.
9. King. RA. Lewis. RA. Townsend. D. Zelickson. A. Olds. DP. Brumbaugh. J. Brown oculocutaneous albinism. Clinical. ophthalmological. and biochemical characterization. Ophthalmology. 1985;92(ll):1496-505.
10. Karaman. A. Oculocutaneous albinism type 1 A: A case report. Dermatol Online J. 2008;14(11):13. Cited at: http://dermatology.cdlib.org/1411/ case-presentations/oca/karaman.html. Accessed on 7/12/2008.
11. Rooryck. C. Roudaut. C. Robine. E. Musebeck. J. Arveiler. B. Oculocutaneous albinism with TYRP1 gene mutations in a Caucasian patient. Pigment Cell Res. 2006;19(3):239-42.
12. Suzuki. T. Tomita. Y. Recent advances in genetic analyses of oculocutaneous albinism types 2 and 4. JDermatol Sci. 2008;5l(l):l-9.
13. Jay. B. Witkop. CJ. King. RA. Albinism in England. Birth Defects. 1982:18:319.
14. Oetting. WS. Brilliant. MH. King. RA. The clinical spectrum of albinism in humans. Mol Med Today. 1996;2(8):330-5.
15. Abadi. R. Pascal. E. The recognition and management of albinism. Ophthalmic Physiol Opt. 1989;9(1):3-15.
16. Meyer. CH. Lapolice. DJ. Freedman. SF. Foveal hypoplasia in oculocutaneous albinism demonstrated by optical coherence tomography. Am J Ophthalmol. 2002;133(3):409-10.
17. Carroll. WM. Jay. BS. McDonald. WI. Halliday. AM. Two distinct patterns of visual evoked response asymmetry in human albinism. Nature. 1980;286(5773):604-6.
18. Gloster. HM. Jr.. Neal. K. Skin cancer in skin of colot.J Am Acad Dermatol. 2006;55(5):741-60; quiz 761-4.